The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Porcine Epidemic Diarrhea Vaccines Market Research Report 2024
Synopsis
Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
The global Porcine Epidemic Diarrhea Vaccines market was valued at US$ 154 million in 2023 and is anticipated to reach US$ 244.7 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Porcine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Epidemic Diarrhea Vaccines.
Report Scope
The Porcine Epidemic Diarrhea Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Porcine Epidemic Diarrhea Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Epidemic Diarrhea Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Epidemic Diarrhea Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Epidemic Diarrhea Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
The global Porcine Epidemic Diarrhea Vaccines market was valued at US$ 154 million in 2023 and is anticipated to reach US$ 244.7 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Porcine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Epidemic Diarrhea Vaccines.
Report Scope
The Porcine Epidemic Diarrhea Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Porcine Epidemic Diarrhea Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Epidemic Diarrhea Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Epidemic Diarrhea Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Epidemic Diarrhea Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Porcine Epidemic Diarrhea Vaccines Market Overview
1.1 Product Overview and Scope of Porcine Epidemic Diarrhea Vaccines
1.2 Porcine Epidemic Diarrhea Vaccines Segment by Type
1.2.1 Global Porcine Epidemic Diarrhea Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Porcine Epidemic Diarrhea Vaccines Segment by Application
1.3.1 Global Porcine Epidemic Diarrhea Vaccines Market Value by Application: (2024-2030)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Porcine Epidemic Diarrhea Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Epidemic Diarrhea Vaccines Revenue 2019-2030
1.4.2 Global Porcine Epidemic Diarrhea Vaccines Sales 2019-2030
1.4.3 Global Porcine Epidemic Diarrhea Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Porcine Epidemic Diarrhea Vaccines Market Competition by Manufacturers
2.1 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Porcine Epidemic Diarrhea Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Product Type & Application
2.7 Porcine Epidemic Diarrhea Vaccines Market Competitive Situation and Trends
2.7.1 Porcine Epidemic Diarrhea Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Epidemic Diarrhea Vaccines Players Market Share by Revenue
2.7.3 Global Porcine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Epidemic Diarrhea Vaccines Retrospective Market Scenario by Region
3.1 Global Porcine Epidemic Diarrhea Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Porcine Epidemic Diarrhea Vaccines Global Porcine Epidemic Diarrhea Vaccines Sales by Region: 2019-2030
3.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Region: 2019-2024
3.2.2 Global Porcine Epidemic Diarrhea Vaccines Sales by Region: 2025-2030
3.3 Global Porcine Epidemic Diarrhea Vaccines Global Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2019-2030
3.3.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2019-2024
3.3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2025-2030
3.4 North America Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2019-2030)
3.4.3 North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2019-2030)
3.5.3 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2019-2030)
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2019-2024)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2030)
4.1.3 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2019-2030)
4.2.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2019-2024)
4.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2025-2030)
4.2.3 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Porcine Epidemic Diarrhea Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2019-2030)
5.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2019-2024)
5.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2030)
5.1.3 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2019-2030)
5.2.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2019-2024)
5.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2025-2030)
5.2.3 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Porcine Epidemic Diarrhea Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CAVAC
6.1.1 CAVAC Corporation Information
6.1.2 CAVAC Description and Business Overview
6.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.1.5 CAVAC Recent Developments/Updates
6.2 Green Cross Veterinary Products
6.2.1 Green Cross Veterinary Products Corporation Information
6.2.2 Green Cross Veterinary Products Description and Business Overview
6.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.2.5 Green Cross Veterinary Products Recent Developments/Updates
6.3 Harrisvaccines
6.3.1 Harrisvaccines Corporation Information
6.3.2 Harrisvaccines Description and Business Overview
6.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.3.5 Harrisvaccines Recent Developments/Updates
6.4 Komipharm
6.4.1 Komipharm Corporation Information
6.4.2 Komipharm Description and Business Overview
6.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.4.5 Komipharm Recent Developments/Updates
6.5 Nisseiken
6.5.1 Nisseiken Corporation Information
6.5.2 Nisseiken Description and Business Overview
6.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.5.5 Nisseiken Recent Developments/Updates
6.6 Qilu Animal Health
6.6.1 Qilu Animal Health Corporation Information
6.6.2 Qilu Animal Health Description and Business Overview
6.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.6.5 Qilu Animal Health Recent Developments/Updates
6.7 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoetis Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Epidemic Diarrhea Vaccines Industry Chain Analysis
7.2 Porcine Epidemic Diarrhea Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Epidemic Diarrhea Vaccines Production Mode & Process
7.4 Porcine Epidemic Diarrhea Vaccines Sales and Marketing
7.4.1 Porcine Epidemic Diarrhea Vaccines Sales Channels
7.4.2 Porcine Epidemic Diarrhea Vaccines Distributors
7.5 Porcine Epidemic Diarrhea Vaccines Customers
8 Porcine Epidemic Diarrhea Vaccines Market Dynamics
8.1 Porcine Epidemic Diarrhea Vaccines Industry Trends
8.2 Porcine Epidemic Diarrhea Vaccines Market Drivers
8.3 Porcine Epidemic Diarrhea Vaccines Market Challenges
8.4 Porcine Epidemic Diarrhea Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
